Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Becton Dickinson, PerkinElmer, and Trinity Biotech

NEW YORK – Trinity Biotech this week announced that it has closed a recently announced refinancing related to all of the outstanding $99.9 million of exchangeable senior notes issued by its subsidiary, Trinity Biotech Investment. The firm closed an $81.25 million senior secured term loan credit facility with Perceptive Advisors, a healthcare investment manager. Proceeds from the term loan along with existing cash and the issuance of new American Depositary Shares will be used to retire approximately $99.7 million of the notes.


Becton Dickinson said this week that its board of directors has approved a quarterly cash dividend of $.87 per share of common stock, to be paid on March 31 to stockholders of record as of March 10. In addition, the firm said the indicated annual dividend rate is $3.48 per share.


PerkinElmer said this week its board has declared a regular quarterly dividend of $.07 per share, payable on May 13 to shareholders of record as of April 22.


In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on 360Dx.